switching from tirzepatide to semaglutide dosing Switching from Semaglutide to Tirzepetide

Wegovy contains semaglutide, a medication that mimics a hormone called GLP-1 (glucagon-like peptide-1)

GLP-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for their effects on weight loss and metabolic health

Coverage is required and generally available with prior authorization

GLP-1 Effects on Appetite Regulation GLP-1R is expressed in the lateral hypothalamus (LH), where animal studies have shown that activation of these receptors decreases appetite [126]

Caution is recommended for those with a history of heart disease as Ozempic may be related to cardiovascular events

Ligaments, tendons, and cartilage that supported a heavier frame must recalibrate their tension and load distribution